Free Cash Flow

After a record 2025 with $51.1M in revenue, the seismic data firm rewards investors, proving its resilience in a volatile Canadian energy market.

North American logistics giant TFI International expands its dedicated services by acquiring Benchmark Logistics and Triangle Warehouse in a key Midwest deal.

Fueled by policy incentives and strong demand, First Solar reports robust 2025 growth and accelerates its US factory expansion, cementing its market leadership.

onsemi will detail its long-term financial and innovation roadmap, focusing on capitalizing on AI, EV, and industrial megatrends amid fierce competition.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

A new giant enters the AI arena. Brookfield launches Radiant to build global 'AI factories,' challenging cloud titans and fueling the race for sovereign AI.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

Target Hospitality is rapidly expanding workforce housing for AI data centers, revealing the massive, unseen physical infrastructure powering the tech revolution.

As Ring Energy preps its Q4 results, investors eye debt reduction, cost control, and 2026 strategy amid a challenging Permian market.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

The coffee giant posts impressive 2025 results amid high inflation, paving the way for its blockbuster acquisition by Keurig Dr Pepper. What's next?

With overwhelming bondholder support, the media giant gains financial flexibility for shareholder returns while tightening protections for its creditors.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

Following strong earnings and a major SAP settlement, Teradata will detail its AI-driven future and financial outlook at two key investor conferences.

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

Industrial packaging giant Greif rewards shareholders, but a closer look at its finances and dual-class stock reveals a company in major transition.

The company's revenue skyrocketed, but SEC filings reveal a story of significant liquidity risks and a bold gamble on the booming wellness market.

A landmark partnership between Grassroots Carbon and Colorado State University is set to validate soil carbon removal, impacting ranchers and corporations.